| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027544 |
| Receipt No. | R000031571 |
| Official scientific title of the study | Anterior Chamber Angle Measurement with Swept-source Optical Coherence Tomography - A Pilot Normative Database Collection Study |
| Date of disclosure of the study information | 2017/06/01 |
| Last modified on | 2018/11/30 (Ver. 3) |
| Basic information | ||||
| Official scientific title of the study | Anterior Chamber Angle Measurement with Swept-source Optical Coherence Tomography - A Pilot Normative Database Collection Study
|
|||
| Title of the study (Brief title) | Anterior Chamber Angle Measurement with SS-OCT | |||
| Region |
|
|||
| Condition | ||
| Condition | healthy subjects, primary angle-closure suspect, primary angle-closure and primary angle-closure glaucoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Primary angle-closure glaucoma (PACG) is a leading cause of irreversible blindness in Asia. It has been estimated that there will be more than 15million people with PACG worldwide by 2020 among which 84.8% are in Asia. As glaucoma is by large asymptomatic, identifying and treating patients at risk of disease progression is fundamental to prevent glaucoma blindness. From primary angle-closure suspect (PACS) (i.e. appositional contact between the peripheral iris and posterior trabecular meshwork for >180 degrees), to primary angle-closure (PAC) (i.e. iridotrabecular contact for >180 degrees together with elevated intraocular pressure (IOP) and / or development of peripheral anterior synechiae(PAS)) and then PACG, primary angle closure diseases forma continuum of progressive disorders of the anterior chamber angle and the optic nerve that would lead to visual impairment and blindness if left undetected. Although the diagnosis of angle-closure has been based on gonioscopic evaluation of iridotrabecular contact, reliable quantification of the anterior chamber angle width is difficult with gonioscopy. With the availability of swept-source optical coherence tomography (SS-OCT), it is feasible to measure the anterior chamber angle dimensions with high reproducibility for 360 degrees. This study aims to collect anterior chamber angle measurements from normal subjects and patients with primary angle closure diseases using the SS-OCT, and develop a normative database for discrimination between primary angle closure eyes and eyes with open angle. The normative database will provide an important clinical tool for clinicians to detect primary angle closure diseases for prevention of disease progression and blindness. |
| Basic objectives2 | Others |
| Basic objectives -Others | To collect anterior chamber angle measurements from normal
subjects and patients with primary angle closure diseases using the SS-OCT. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The scan protocols comprise (1) custom 'Lens biometry' which includes 18 radial B-scans (800 A-scans/B-scan), each with 16 mm in length and 14 mm in depth and (2) 'Anterior segment' which includes 16 radial B-scans (800 A-scans/B-scan), each with 16 mm in length and 11 mm in depth. Eyes will be imaged in the dark (<1.0 lux) for three times with custom 'Lens Biometry' and once with 'Anterior segment'; and then in room light (needs to standardize the room light illumination) for three times with custom 'Lens Biometry' and once with 'Anterior segment'. |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Japanese healthy subjects and/or patients with primary angle closure glaucoma (PACG)
1. over 40 years 2. eyes not performing cataract surgery 3. maximum visual acuity more than 0.5 4. spherical equivalent (refraction) more than -1.0 diopters Normal eyes always show normal intraocular pressure (from 10 to 21 mmHg), have an open angle, and have no glaucomatous optic neuropathy Glaucoma is an eye with characteristic morphological changes of the optic disc or retinal nerve fiber and corresponding visual field defects PACG is classified as follows according to angular examination and intraocular pressure .primary angle closure suspect(PACS) .primary angle closure (PAC) .primary angle closure glaucoma (PACG) |
|||
| Key exclusion criteria | Those who do not meet inclusion criteria from 1 to 4
Secondary glaucoma, eyes after intraocular surgery including laser treatment, eyes with strong cataract, those who can not conduct reliable examination |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Makoto Aihara |
| Organization | The University of Tokyo hospital |
| Division name | Department of ophthalmology |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan |
| TEL | 03-3815-5411 |
| aihara-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | Rei Sakata |
| Organization | The University of Tokyo hospital |
| Division name | Department of ophthalmology |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan |
| TEL | 03-3815-5411 |
| Homepage URL | |
| reisakata-tky@umin.ac.jp | |
| Sponsor | |
| Institute | The Chinese University of Hong Kong |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tomey Corporation Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学医学部附属病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031571 |